DUBLIN, Ireland – Elan Corp. plc is hiving off its early stage neurology drug discovery activity into a new entity, Neotope Biosciences, which will begin life with $120 million to $130 million in cash and seek a listing on an as yet to be determined U.S. exchange.
DUBLIN, Ireland – Elan Corp. plc is hiving off its early stage neurology drug discovery activity into a new entity, Neotope Biosciences, which will begin life with $120 million to $130 million in cash and seek a listing on an as yet to be determined U.S. exchange.
The drug development graveyard that is sepsis claimed another victim Wednesday, as AZD9773 (CytoFab), which AstraZeneca plc was developing with BTG plc, failed to separate from placebo in a Phase IIb trial in 300 patients with severe sepsis or septic shock.
Shares in Allergy Therapeutics plc surged 36 percent Friday on news that the FDA had finally lifted a five-year clinical hold on the development of its Monophosphoryl Lipid A (MPL)-adjuvanted grass pollen allergy vaccine (Grass MATA MPL/ Pollinex Quattro Grass 0.5ml) and had cleared a Phase III protocol for determining the product's efficacy.
Pharming Group NV is planning to downsize operations at its headquarters in Leiden, the Netherlands, and has put in place additional working capital facilities as its day of reckoning approaches.
DUBLIN, Ireland – Now that the great carnival that is the Euroscience Open Forum (ESOF) has folded its tent and set a course for Copenhagen, Denmark, it is clear that the event – the biggest ever general scientific meeting in Ireland – marks a turning point in the country's maturing engagement with research.
DUBLIN, Ireland – Dublin's undpredictable weather, a confounding blend of sunshine, wind and rain, was an apt metaphor for the mix of optimism, realism and disappointment that could be heard in the many scientific sessions during the first full day of the Euroscience Open Forum 2012 (ESOF 2012) meeting at the Convention Centre Dublin Thursday.
